KDR and neoplasm: We have developed an analytically robust IHC assay for determination of VEGFR2 expression on archival human tumor tissues using a technically sound assay development and optimization approach that included high quality human tissues, confirmation of assay specificity and selectivity, stringent quality control, and analytical validation.